On September 9, 2019 Cellular Biomedicine Group Inc. (NASDAQ: CBMG) ("CBMG" or the "Company"), a biopharmaceutical firm engaged in the drug development of immunotherapies for cancer and stem cell therapies for degenerative diseases, reported that the Company will present at the upcoming Annual CAR-TCR Summit in Boston, MA September 10-13, 2019 (Press release, Cellular Biomedicine Group, SEP 9, 2019, View Source [SID1234539388]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Wednesday, September 11, 2:47pm
Yihong Yao, PhD, Chief Scientific Officer
"Meeting the Challenge of Delivering Cell & Gene Therapy Products to Patients in China"
Medical digitalization will fundamentally transform research, clinical, and healthcare as a whole
How China can advance the progress in novel therapy modalities
De-risking clinical trials by leveraging fast-track clinical studies
A copy of the presentation will be made available on the Company’s website following the presentation.